AIT Therapeutics Inc Share Price OTC Bulletin Board
Equities
Medical Equipment, Supplies & Distribution
Sales 2024 * | 1.44M 120M | Sales 2025 * | 13.2M 1.1B | Capitalization | 53.47M 4.46B |
---|---|---|---|---|---|
Net income 2024 * | -62M -5.17B | Net income 2025 * | -64M -5.34B | EV / Sales 2024 * | 28.7 x |
Net cash position 2024 * | 12.15M 1.01B | Net Debt 2025 * | 2.95M 246M | EV / Sales 2025 * | 4.28 x |
P/E ratio 2024 * |
-0.6
x | P/E ratio 2025 * |
-0.64
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 82.02% |
Latest transcript on AIT Therapeutics Inc
Managers | Title | Age | Since |
---|---|---|---|
Steven Lisi
CEO | Chief Executive Officer | 53 | 13/17/13 |
Douglas Larson
DFI | Director of Finance/CFO | 53 | 01/21/01 |
Amir Avniel
PSD | President | 50 | 13/17/13 |
Members of the board | Title | Age | Since |
---|---|---|---|
Ronald Bentsur
BRD | Director/Board Member | 58 | 01/15/01 |
William Forbes
BRD | Director/Board Member | 62 | 13/18/13 |
Erick Lucera
BRD | Director/Board Member | 57 | 10/17/10 |
1st Jan change | Capi. | |
---|---|---|
-2.31% | 187B | |
-3.20% | 106B | |
-5.04% | 66.9B | |
+0.20% | 49.45B | |
+17.29% | 48B | |
+4.06% | 40.84B | |
+2.07% | 26.48B | |
+2.36% | 26.25B | |
+12.96% | 24.62B |